These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

668 related items for PubMed ID: 9346216

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Carboplatin plus paclitaxel in the treatment of gynecologic malignancies: the Cleveland Clinic experience.
    Markman M, Kennedy A, Webster K, Kulp B, Peterson G, Belinson J.
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-26-S15-29. PubMed ID: 9346218
    [Abstract] [Full Text] [Related]

  • 3. Chemotherapy for ovarian cancer: an evidence-based approach.
    Geisler JP, Manahan KJ, Wiemann MC.
    Minerva Ginecol; 2004 Dec; 56(6):539-45. PubMed ID: 15729206
    [Abstract] [Full Text] [Related]

  • 4. Chemotherapy for gynecologic cancers.
    Rahaman J, Steiner N, Hayes MP, Chuang L, Fishman D, Gretz Iii H.
    Mt Sinai J Med; 2009 Dec; 76(6):577-88. PubMed ID: 20014427
    [Abstract] [Full Text] [Related]

  • 5. [Pharmacotherapy in ovarian carcinoma].
    Pfisterer J, Du Bois A.
    MMW Fortschr Med; 2005 Oct 27; 147(43):34-6. PubMed ID: 16302419
    [Abstract] [Full Text] [Related]

  • 6. Adjuvant therapy in gynecologic malignancies. Ovarian, cervical, and endometrial cancer.
    Curtin JP, Shapiro F.
    Surg Oncol Clin N Am; 1997 Oct 27; 6(4):813-30. PubMed ID: 9309095
    [Abstract] [Full Text] [Related]

  • 7. Recent advances in the management of women with ovarian cancer.
    Eltabbakh GH.
    Minerva Ginecol; 2004 Feb 27; 56(1):81-9. PubMed ID: 14973412
    [Abstract] [Full Text] [Related]

  • 8. Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers.
    Muggia FM.
    Semin Oncol; 2004 Dec 27; 31(6 Suppl 14):17-24. PubMed ID: 15726530
    [Abstract] [Full Text] [Related]

  • 9. Gynecological cancers.
    Boente MP, Schilder R, Ozols RF.
    Cancer Chemother Biol Response Modif; 1999 Dec 27; 18():418-34. PubMed ID: 10800496
    [No Abstract] [Full Text] [Related]

  • 10. Carboplatin and paclitaxel in advanced or metastatic endometrial cancer.
    Pectasides D, Xiros N, Papaxoinis G, Pectasides E, Sykiotis C, Koumarianou A, Psyrri A, Gaglia A, Kassanos D, Gouveris P, Panayiotidis J, Fountzilas G, Economopoulos T.
    Gynecol Oncol; 2008 May 27; 109(2):250-4. PubMed ID: 18299146
    [Abstract] [Full Text] [Related]

  • 11. [Studies on additional Iscador therapy in the management of women with surgically and radiotherapeutically treated genital carcinoma].
    Leroi R.
    Gynaecologia; 1969 May 27; 167(3):158-70. PubMed ID: 4305038
    [No Abstract] [Full Text] [Related]

  • 12. [Taxol in advanced cervical cancer].
    Hirabayashi K, Ito J, Kobayashi M, Numa F, Ito T.
    Nihon Rinsho; 2004 Oct 27; 62 Suppl 10():179-82. PubMed ID: 15535229
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study.
    Pujade-Lauraine E, Guastalla JP, Weber B, Curé H, Orfeuvre H, Mousseau M, Vincent P, Diéras V, Tubiana-Mathieu N, Jacquin JP, Mignot L, Leduc B, Paraïso D, Viens P.
    Semin Oncol; 1997 Oct 27; 24(5 Suppl 15):S15-30-S15-35. PubMed ID: 9346219
    [Abstract] [Full Text] [Related]

  • 14. [A trial of biweekly paclitaxel administration in consideration of QOL for advanced or recurrent gynecologic cancer].
    Fushiki H, Yoshimoto H, Ikoma T, Ota S.
    Gan To Kagaku Ryoho; 2005 May 27; 32(5):691-3. PubMed ID: 15918575
    [Abstract] [Full Text] [Related]

  • 15. Salvage weekly paclitaxel in recurrent ovarian cancer.
    Abu-Rustum NR, Aghajanian C, Barakat RR, Fennelly D, Shapiro F, Spriggs D.
    Semin Oncol; 1997 Oct 27; 24(5 Suppl 15):S15-62-S15-67. PubMed ID: 9346225
    [Abstract] [Full Text] [Related]

  • 16. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
    Trimbos JB, Vergote I, Bolis G, Vermorken JB, Mangioni C, Madronal C, Franchi M, Tateo S, Zanetta G, Scarfone G, Giurgea L, Timmers P, Coens C, Pecorelli S, EORTC-ACTION collaborators. European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm.
    J Natl Cancer Inst; 2003 Jan 15; 95(2):113-25. PubMed ID: 12529344
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and tumor uptake of a derivatized form of paclitaxel associated to a cholesterol-rich nanoemulsion (LDE) in patients with gynecologic cancers.
    Dias ML, Carvalho JP, Rodrigues DG, Graziani SR, Maranhão RC.
    Cancer Chemother Pharmacol; 2007 Jan 15; 59(1):105-11. PubMed ID: 16699792
    [Abstract] [Full Text] [Related]

  • 18. Medical treatment of epithelial ovarian cancer.
    González-Martín AJ.
    Expert Rev Anticancer Ther; 2004 Dec 15; 4(6):1125-43. PubMed ID: 15606338
    [Abstract] [Full Text] [Related]

  • 19. Gynecologic cancers.
    Boente MP, Schilder R, Ozols RF.
    Cancer Chemother Biol Response Modif; 1997 Dec 15; 17():536-61. PubMed ID: 9551230
    [Abstract] [Full Text] [Related]

  • 20. [Standard of chemotherapy in ovarian cancer].
    Pfleiderer A, Meerpohl HG.
    Chirurg; 1994 Jan 15; 65(1):18-22. PubMed ID: 8149794
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.